White Paper 13: The 1:500 Parity Ratio Modeling Preventative Footwear as Durable Medical Equipment to Mitigate Acute Trauma Liabilities

Title: Biomechanical Footwear as Essential Durable Medical Equipment: A Cost-Benefit Analysis of Preventative Orthopedic Coverage in Mitigating Falls, Emergency Admissions, and Catastrophic Healthcare Expenditure
Target Audience: Centers for Medicare & Services (CMS), Private Payer Actuarial Committees, State Medicaid Directors, Value-Based Care Policy Analysts
Domain: Health Economics, Biomechanics, Injury Epidemiology, Health Policy

1. Executive Summary

Falls among older adults and individuals with neurological, musculoskeletal, and sensory impairments constitute an under-managed financial and structural liability within the United States healthcare apparatus. Current national health expenditures attributable to falls exceed $50 billion to $80 billion annually, with more than 70% of those costs absorbed by public payers (Medicare and Medicaid).

A critical structural defect in current healthcare reimbursement policy is the statutory exclusion of non-diabetic therapeutic footwear. While Medicare and commercial payers comprehensively fund high-cost rigid bracing (such as Ankle-Foot Orthoses / AFOs) and post-traumatic acute surgical reconstructions, they categorize the foundational mechanical interface—the shoe—as a non-covered “personal convenience item,” unless tied exclusively to a diabetic metabolic diagnosis (HCPCS A5500 series).

This white paper models the actuarial and clinical outcomes of introducing a standardized, restricted Durable Medical Equipment (DME) Footwear Formulary offering a $200 annual allocation for verified, functional, torsionally stable footwear. Assuming an empirical 25% self-selected utilization rate among an insured cohort of 1,000,000 lives and a conservative 10% reduction in mechanical fall incidence, the policy generates:

  • Gross Preventative Capital Outlay: $50,000,000 annually.
  • Direct Acute Care and ER Savings: $125,000,000 annually.
  • Net Annual Liquidity Dividend: $75,000,000 per 1,000,000 covered lives (a 2.5:1 Return on Investment in Year 1).
  • The “One-for-500” Parity Ratio: The avoided direct surgical and post-acute cost of a single catastrophic trimalleolar or femoral fracture ($100,000) fully underwrites the preventative footwear allocation for 500 vulnerable individuals.

2. Problem Statement & Regulatory Defect

2.1 The Actuarial Cost of Acute Falls and Emergency Over-Utilization

Falls represent the leading cause of non-fatal and fatal injury among adults aged 65 and older, as well as the primary driver of preventable trauma admissions across populations with hereditary motor-sensory neuropathies (e.g., Charcot-Marie-Tooth disease, Hereditary Neuropathy with Liability to Pressure Palsies [HNPP]), spinal cord pathologies, and post-arthrodesis balance deficits.

  • Emergency Department (ED) Volume: Over 3.0 million older adults are treated in hospital emergency departments annually for fall-related injuries.
  • Inpatient Escalation: Roughly 800,000 fall patients per year require emergent inpatient admission, overwhelmingly driven by hip fractures (ICD-10 S72), traumatic brain injuries (ICD-10 S06), and complex trimalleolar/bimalleolar ankle fracture dislocations (ICD-10 S82).
  • The ED Diversion Failure: When an individual with distal lower-extremity sensory loss or foot drop experiences sudden lateral instability, the lack of structural torsional resistance leads directly to mechanical failure. The emergency department is routinely utilized as an expensive, low-efficiency triage mechanism for balance-loss trauma that proper mechanical ground-coupling systematically prevents.

2.2 The Statutory Anomaly: The Diabetic Footwear Silo

The Medicare Therapeutic Shoe Bill (enacted under OBRA 1993) created HCPCS billing codes A5500 through A5514 (extra-depth, custom-molded shoes and inserts). However, the statutory language strictly limits reimbursement to patients with a primary diagnosis of Diabetes Mellitus (ICD-10 E08-E13) exhibiting specific secondary criteria (ulceration, callus, or diabetic neuropathy).

The pathway illustrates the coverage breakdown for patients experiencing peripheral neuropathy and loss of sensation:

  • Metabolic Origin (Type 2 Diabetes): Falls under HCPCS A5500, with 100% of therapeutic depth shoes and custom inserts fully covered and reimbursed.
  • Genomic Origin (HNPP / CMT / Spine): Deemed Non-Covered, resulting in a categorical exclusion and 100% out-of-pocket costs for the patient.

The Clinical Absurdity: A patient with hereditary neuropathy (such as PMP22 haploinsufficiency) or adjacent segment spinal biomechanical instability presents with identical or superior tissue fragility, mechanical shear vulnerability, and fall probability compared to a patient with diabetic neuropathy. Yet, because their neuropathy is genomic rather than metabolic, the claim is rejected at the electronic data interchange (EDI) clearinghouse level.

2.3 The “Brace Without an Enclosure” Disconnect

Insurers routinely authorize $1,500 to $5,000 for custom carbon-fiber or thermoplastic Ankle-Foot Orthoses (HCPCS L1900 series). However, standard commercial off-the-shelf footwear cannot accommodate the volumetric displacement of an AFO calf shell, footplate, and strut without creating severe focal pressure points. When patients are forced to purchase cheap, non-depth retail footwear, the brace compresses cutaneous nerves against rigid seams, precipitating secondary pressure-induced palsies, skin necrosis, or intentional abandonment of the brace-re-establishing catastrophic fall risk.

3. The Preventative Footwear Formulary (PFF) Model

To prevent cosmetic consumer leakage (subsidizing fashion athletic shoes or unsupportive footwear), the benefit must not function as an unrestricted open-retail cash stipend. Instead, it must be structured as a Vetted Biomechanical Formulary, modeled after a standardized Pharmacy & Therapeutics (P&T) formulary.

3.1 Closed Technical Specifications (Eligibility Matrix)

Footwear eligible for the $200 annual DME allowance must satisfy strict structural criteria verified by independent biomechanical testing:

  • Torsional Rigidity: Must require longitudinal and midfoot torsional resistance; presence of a composite, steel, or high-modulus thermoplastic shank. This prevents midfoot collapse and high-energy lateral inversion rolling during mid-stance.
  • Heel Counter Rigidity: Minimum Shore A hardness (>70) reinforced thermoplastic or multi-layer leather heel counter; zero medial/lateral collapse under 25 lbs force. This centers the calcaneus, stabilizes subtalar joint pronation/supination, and controls hindfoot sway.
  • Volumetric Clearance: Minimum 3/8-inch to 1/2-inch internal extra-depth throughout the footbed; removable dual-layer spacer system. This accommodates internal AFO footplates and custom orthoses without dorsal or malleolar nerve compression.
  • Outsole Architecture: Flared heel base with beveled or rockered heel strike; slip-resistant rubber compound (ASTM F2913 / F1677 coefficient of friction >0.5). This reduces initial ground-strike trip risk, promotes smooth sagittal roll-through, and stabilizes stance.
  • Seamless Interior: Padded, seamless inner lining across dorsal, medial, and lateral metatarsal zones. This prevents cutaneous friction blisters, pressure palsies, and skin ulceration in insensate/demyelinated tissue.

3.2 Manufacturer Certification & Commercial Access

  • Core Formulary (Tier 1): Pre-screened manufacturers whose dedicated stability/work/hiking lines natively meet the mechanical requirements (e.g., Brooks Addiction/Beast motion-control series, Merrell rigid-chassis Moab/Jungle Moc work series, Timberland PRO rigid-shank boots, Orthofeet/Drew medical depth shoes).
  • Tier 2 (Commercial Evaluation): Consumer lifestyle manufacturers (Nike, Skechers, Reebok) may only enter the formulary if specific SKUs undergo accredited independent lab certification proving torsional stiffness and non-slip metrics.
  • Point-of-Sale Execution: Claims clear via dedicated medical OTC flex debit cards or directly at in-network orthotics suppliers through restricted Universal Product Codes (UPCs) and National Drug Code (NDC)-equivalent product registries.

4. Health Economic & Actuarial Model

4.1 Cohort Architecture & The Breakage Principle

  • Base Risk Pool: 1,000,000 covered commercial / Medicare Advantage / Managed Medicaid lives.
  • Benefit Amount: Up to $200.00 per member per calendar year.
  • Benefit Utilization Factor (Breakage): 25% (250,000 active participants; 750,000 non-participants).

In health plan design, preventative voluntary benefits exhibit a high breakage rate (unclaimed funds). The 25% of subscribers who actively navigate benefit portals to acquire rigid-shank, motion-control footwear represent a self-selected, risk-weighted demographic: individuals with active foot pain, balance instability, occupational concrete exposure, or neuro-spinal deficits. The program naturally concentrates its resources on the highest-yield segment of the population.

Total Population breakdown: Out of 1,000,000 covered lives, 75% (750,000) are non-users, resulting in $0 outlay. The remaining 25% (250,000) represent high-risk, self-selected users, receiving a $200 allocation for a total of $50,000,000 in program investment.

4.2 Acute Injury Costs (The Cost of Inaction)

When an individual without stable footing experiences a lateral inversion failure or sudden slip, the resulting acute medical pathway generates catastrophic claims:

  • Emergency Medical Transport (Ambulance): $1,500 – $2,500
  • Emergency Department Level 5 Facility Fee: $3,500 – $6,000
  • Diagnostic Imaging (CT / Bi-Planar X-Ray): $2,000 – $4,500
  • Surgical Intervention (ORIF Ankle/Femur): $45,000 – $65,000
  • Anesthesia & Inpatient Surgical Suite Fees: $12,000 – $18,000
  • Inpatient Recovery (3-5 Days Acute Bed): $15,000 – $25,000
  • Post-Acute Skilled Nursing Facility (SNF): $10,000 – $20,000
  • Outpatient Physical/Occupational Therapy: $3,000 – $6,000
  • TOTAL DIRECT EPISODE CLAIMS COST: $92,000 – $147,000 (Median: ~$100,000)

5. Cost-to-Savings Analysis

5.1 The 1-to-500 Parity Ratio

The economic viability of preventative footwear rests on an unprecedented asymmetric capital ratio:

  • Single Catastrophic Fall Cost: $100,000
  • Footwear DME Allocation: $200
  • Parity Ratio: $100,000 / $200 = 500 : 1

The 1:500 Axiom: Preventing exactly one catastrophic surgical trauma admission fully amortizes the hardware subsidy for five hundred individuals.

5.2 Population Ledger (1 Million Covered Lives)

To achieve break-even on a $50,000,000 gross program expenditure across 250,000 active participants:

  • Break-Even Calculation: $50,000,000 / $100,000 = 500 Catastrophic Events

Across 250,000 high-risk individuals, avoiding 500 catastrophic fractures requires an incidence reduction of merely 0.2% (2 per 1,000 members per year). Epidemiological studies demonstrate that stabilizing footwear with rigid heel counters and high-traction outsoles reduces fall-related biomechanical failure by 10% to 24%.

The annual actuarial ledger for 1,000,000 covered lives at 25% utilization is structured as follows:

  • PROGRAM DEBITS (EXPENDITURE):
    • 250,000 members x $200.00 DME Voucher Allocation: ($50,000,000)
    • Administrative clearinghouse / formulary management overhead (5%): ($2,500,000)
    • TOTAL GROSS PROGRAM INVESTMENT: ($52,500,000)
  • PROGRAM CREDITS (SAVINGS REALIZED):
    • Avoided Inpatient Trauma (1,250 prevented fractures @ $100,000): +$125,000,000
    • Avoided Emergency Department Fall Presentations (Uncomplicated): +$4,500,000 (3,000 avoided ED visits @ $1,500 facility/triage cost)
    • Avoided Outpatient Imaging & Soft-Tissue Rehab Claims: +$3,000,000
    • TOTAL GROSS AVOIDED CLAIMS OFFSET: +$132,500,000
  • NET ANNUAL BALANCE SHEET DIVIDEND: +$80,000,000
  • NET RETURN ON INVESTMENT (ROI): 2.52 : 1

6. Downstream Hospitalization & ED Decongestion (The Systemic Bonus)

Beyond the balance sheet of the individual health insurer, implementing a preventative footwear DME benefit addresses critical structural bottlenecks across the American hospital infrastructure:

  • Emergency Department Diversion: Fall-related presentations frequently require Level 4 and Level 5 trauma bay triage, comprehensive multi-slice CT scans (cervical spine, head, and pelvis), and prolonged nursing observation. Decongesting non-emergent, preventable lower-extremity balance trauma directly reduces hospital bed-hold hours, relieves boarding crises in emergency departments, and shortens emergency ambulance turnaround intervals.
  • Elimination of Secondary Iatrogenic Complications: In elderly and neuropathic patients, emergent surgical admission for fracture fixation carries severe secondary clinical risks: hospital-acquired infections (MRSA/C. diff), delirium, rapid muscle deconditioning, and pressure injuries. By eliminating the primary trauma event, the system circumvents the catastrophic functional spiral that so often transitions a community-dwelling individual into a long-term, state-subsidized skilled nursing facility.
  • Preserving Workplace Productivity: For working-age individuals with physical disabilities, spinal fusions, or hereditary neuropathies, proper footwear preserves the ability to maintain active employment, reducing disability claims (SSDI) and stabilizing tax bases.

7. Policy Recommendations & Implementation Roadmap

  • Phase 1: Regulatory Reclassification
    • Remove “for diabetics only” statutory prefix from HCPCS A5500.
    • Establish generic qualifying criteria: ICD-10 G60.0, M43.1, R26.81.
  • Phase 2: Formulary Construction
    • Partner with clinical biomechanics labs to define rigid testing specs.
    • Publish approved manufacturer list (Merrell, Brooks, Timberland, etc.).
  • Phase 3: Point-of-Sale Integration
    • Route funds through restricted medical OTC/DME clearinghouse cards.
    • Enforce SKU-level verification to prevent cosmetic retail leakage.

7.1 Federal Action (CMS & Congress)

  • Modernize Title XVIII of the Social Security Act: Amend the Therapeutic Shoe Bill to remove the etiological restriction on Diabetes Mellitus. Re-title the statutory benefit: “Therapeutic and Biomechanical Footwear for Loss of Protective Sensation and Structural Mobility Impairments.”
  • HCPCS Code Descriptors: Revise HCPCS codes A5500-A5514 by replacing the phrase “For diabetics only” with “For individuals with metabolic, genomic, or biomechanical neurological deficit.”
  • Recognize Hereditary Neuropathies: Explicitly list Hereditary Motor and Sensory Neuropathies (ICD-10 G60.0), post-fusion cervical/lumbar adjacent segment instability (M99.8 series), and cerebellar ataxia (G11 series) as automatic qualifying diagnostic prerequisites.

7.2 Private Payer & Medicare Advantage Execution

  • Special Supplemental Benefits for the Chronically Ill (SSBCI): Managed care organizations (MA-PD and D-SNP plans) should immediately deploy preventative footwear allowances under existing SSBCI authority, capturing immediate medical loss ratio (MLR) savings.
  • Closed-Loop Retail Integrations: Insurers should partner directly with medical supply distributors, certified pedorthic facilities, and approved retail suppliers utilizing barcode-level clearinghouses to verify that funds cannot be applied to unapproved lifestyle footwear.

8. Conclusion

The exclusion of protective, biomechanically vetted footwear from standard healthcare coverage represents an unsustainable actuarial paradox. The modern healthcare enterprise routinely expends $100,000 to surgically reconstruct an ankle or pelvis shattered on the pavement, yet denies a $200 investment that maintains the patient’s ground stability.

The arithmetic of preventative footwear is incontrovertible:

  • Preventing one catastrophic injury finances the defensive footwear of five hundred vulnerable citizens.
  • Capturing a modest 10% reduction in fall incidence across an insured pool recovers billions of dollars in preventable acute trauma expenses, decongests hospital emergency rooms, and protects human autonomy.

Transitioning footwear from an uninsured consumer commodity to a certified, formulary-controlled DME asset is a fiscally conservative, clinically rigorous imperative. The healthcare system must stop allocating unlimited capital to sweep up the broken pieces of human machinery when it can keep the machine upright for the price of a pair of shoes.

(Frankenshoes Followup) Salomon X ULTRA PIONEER MID with Carhartt Insoles

Shoes are an occasional topic here and I have had a few posts with shoes but this one has to be the strangest follow-up. I had Solomon X ULTRA PIONEER MID shoes and the insoles wore out fast which sucks but, as someone who doesn’t drive I expect these things. My normal go to shoes are Merrell or Salomon, Merrell are the go to war boots that survive just about everything, Solomon are the light weight shoes you do the million mile march in and they keep going.

But sometimes insoles do wear out , and they make life horrible. They are the inner base of the shoe that makes your day horrible or they make the many steps on your feet not feel like you are playing the drums with your feet. The insole was wandering around the shoe making pain in my feet. I deal with a lot of pain in my feet on the day to day as i am prone to muscle spasms .

Salomon – with their lightweight shoes, they somehow do cut the divide of weight and utility perfectly. They do not fall apart , they last for years. After buying these in early winter I wore these day to day as the traveling shoe. they manage to stay warm in winter and do not leak .. But I did notice the insole starting to shed its lining. A week ago went on a quest to replace the insole with preferably the insole that belongs with the shoes. Merrell does it I figured a higher end Mid would do the same.. No. I looked for an hour and kept falling back to the Carhartt Insite Technology Footbed CMI9000 Shoe Accessory. After Two days they shipped in and I was initially worried they would not fit.

They fit well into the shoe, they had a raised arch to comfort the arch, i put them on and thought this might cause pain and instead i decided to press on and see how it went. After a day the arch relaxed into the Mid , The insole more or less perfectly formed into place. while it adds a bit of weight the comfort level definitely went up.

Mentally… when you do something like this, it feels like using a Toyota part on a ford, Which to the average person would seem like a mortal sin. But the secret here is what the industry tries to make you not pay attention to, That parts can be used on other manufacturer parts within reason.

So when you do the math, I am taking an insole meant for people who do construction all day where weights and tolerances need to be at the top, than place it into a shoe that balances high impact and survivability . Conventionally i just took the best of both worlds where repeated day to day use has a base that is form fitting and comfortable to the point of repeated usage plays out to a higher degree.

While this only a week into this, One could hope this is a force multiplier and a message to a both companies. Carhartt makes boots to survive the Armageddon Salomon makes shoes to climb the armageddon, there is a convergence that both companies are missing here….

So my not so closing thought here is, Sometimes instinct of doing something may not be enough but sometimes taking the gut feeling leap of “this might work” sometimes pays off in kind. So if you need extra miles and extra comfort this frankenshoe experiment shall continue…

Weird things to do with shoes , review- (Carhartt, Insoles with Insite® Technology, CMI9000)

Every now and then you need comfort in shoes, and being like me, I was feeling something in my shoes and the insoles were wearing out and a somewhat new pair of shoes. I do not tend to wear sneakers, due to no ankle support. I wear waterproof hikers year around just about because most time hikers support the arch and makes it easier to walk, as I do have disabilities.

But for the insole to self destruct in only less than 8 months of owning a shoe is pretty bad even though that The Solomon X ULTRA PIONEER MID is a Fantastic shoe. So looking around amazon I saw many insoles, most looking like pure foam and on stuff that is foam I need to use care in selecting a insert, because too much foam like sketchers is an easy path for me to fall on my face.

Given that Solomon does one bad thing here, They do not sell replacement Insoles for their shoes and that should be considered sin. Because a high end hiker that does not support their own brand force the user down the planned obsolescence route is ridiculous.

So I went with Carhartt Men’s Insite Footbed CMI9000 Insole, I figured the look the part. It took a day or two to get them and you know what.. they fucking fit. what surprised me is the amount of arch support. I know these are likely for carhartt boots but, I am willing to science it up for science.

So give or take this Franken-shoe or Dr Solomon and Mr Carthartt hide.. Test will be interesting.. Usually shoe companies do not play nice with each other. so given the fact that these solomon shoes that cost over 179$ and having a insole that died in months. Im willing to give the Carhartt insoles and chance and see what happens. who knows in a week I could be bitching my foot hurts. But you know what , if it works lets see..

I’m giving this a rating of a review in progress…

We are seeing the .com Bust and the Gold Rush playing out in real time.

Some mornings I take a peek at the news and I just read up on things while I wait for my coffee, and one article caught my attention.

Struggling shoe retailer Allbirds makes bizarre pivot to AI, adds $127 million in value

Shoes to …AI ? Did I read that right. Yes I did . The first thing that came to mind was SouthPark. than The 1990s.

A Business pivots so hard that even a contortionist goes damn!

Give or take right now, AI is “hot” but, it’s as hot as running a building full of graphics cards with a failing cooling system. The thing is ALLBIRDS reads as a master class of failure. They make shoes, The shoes become popular. Allbirds leverages itself that they are the Steve Jobs of shoes and don’t read the room. Two years out they are sputtering and failing and have not become the next reebok or nike. They come up with a “brilliant” plan , They sell off all of their assets and jump on the AI train. ALLBIRD than renames themselves to NEWBIRD AI. Sure sure they likely wanted to create an image like they were a phoenix reborn from the ashes of their old company. But they missed out .. ALLbird to AIBIRD (which would of been perfect. like the mimicry of a parrot?). They could of adjusted there merch with a sharpie at that point.

But here’s the thing. A shoe maker has a soft fail, they could of sold off all of the assets that was shippable. Clearance out the shoes, Leverage out the lower markets and find out if the non tech-bro market liked the shoes and pivot there. Less risk than buying the AI lottery ticket. The fact they exited the shoe market at 39 million means they were not cratored.

They have Zero experience in the AI market. They have nothing other than cash to invest, Than they spoke the word they are going to invest an AI and than the venture vultures came. There market cap climbed to 148m . The funny thing is this is all speculative. like the .com bubble. Everyone is jumping in. NEWBIRD AI doesn’t even have land yet, they need to get in line for AI infrastructure, they need to find land that will not overwhelm local infrastructure. So right now they are selling their vision on a feverdream that by the time it comes to realization may be gone.

If ALLBIRD was a tech startup and they had some revolutionary code to help AI this would be a viable path but in the end, this is a shoe company that is buying a shovel from NVidia and trying to be the next big thing when the shovel is a kids play shovel and other companies are using construction machines in the AI market with very small to negative returns.

One last thing, “Stockholders are also asked to approve a charter amendment to remove the company’s environmental conservation public benefit and to authorize a plan of dissolution the Board could implement within 12 months.” Talk about the Theoretical take away from this. live in good nature and ecology than, setting your customer base on fire pissing on the fire and walking away from your mission statement.

For Allbird, They could of paired down the back stock . Sent shoes to influencers , built a brand on tiktok with a close enough reproduction , Kept there ecologically sounding mission statement, built an entire sector off of sephora girls and won big off of “vibes”.

The worst part of all of this, is this is an AI adjacent, that needed to talk about no technology and honestly the fucktons of money thrown at nothing. New Bird AI might be the Futures New Turd AI.

update: You know its bad when Voidzilla enters the conversation….

Teva Shoes the revisit.

A shoe post! It has been ages since i’ve posted anything about shoes , the last time I did was due to a problem to which Teva/Decker shoe company where absolutely incredible helping me out with getting my shoes replaced. Since then I’ve stuck with the company and their shoes due to there reliability, My most recent pair of shoes was a pair of the TEVA Churn Watershoe.

Although most sites list these as a watershoe I can not say that they are since I’ve never tested them in water, they have been my day to day shoes for the entire summer. as far as fit , they are a seemingly good fit and remind me of the Teva X-1 Control shoe. Why Teva ever stopped making these shoes is beyond me… If anyone out there from Teva is watching , Please bring back these shoes, those were about the best shoes I’ve owned and I had 2 pairs of those,  They weighed next to nothing and were extremely comfortable, The Churn though could be regarded as the cousin to these, while not as rugged as the X-1’s the style of the shoe is based on alike construction and weight although the major differences are in the treads of the shoes the Churns are more like road wear while the X-1 were trail wear.  But both shoes are very alike in construction and weight , they are almost like wearing socks treads . If you are on your feet all day these will stand up to the test of the day , I’ve worn shoes that you want to light on fire just to feel a bit more comfortable because the heel or other parts of your foot are in agony .

 

For the churns I’ve done a ton of walking in them and they do not wear as easy as the X-1s, If you do alot of road walking or walking in building these are the shoes for you, the no lace thing is also very nice due to the fact you can throw them on in a hurry if you are going out.

 

So my opinion for the shoes.. Awesome!

*Yes! I get to use the shoe tag!

Fun With Teva shoes

In the early half of 2009,  I purchased Teva aravalli mens shoes. For years I have worn Teva shoes since Timberland shoe quality went downhill.  Now since I do not drive a car, quality of shoes are important to me.

Around Mothers Day in 2009 I purchased these shoes and out of the store they were very comfortable. but, after a month these shoes started to fall apart which aggravated me.  The glue to hold the sole together had was very inferior due to the fact that the more you walked the more that the sole separated from the shoe.

After I had returned the first pair I figured that the shoes were a fluke.  In june I the second pair and those too fell apart in no time.   Since I needed shoes and the older Teva shoes I had some holes in them, the retailer I bought the shoes from did everything in there power to help me out, but to no avail. finally I had emailed Decker shoes the parent company of Teva figuring that i’d get no response. About a week late to my surprise I received an email back

Hi Mike

Thanks for your email.  Honestly.  We really appreciate you taking some time to connect with us and share your feedback.

First, I’m sorry to hear of your most recent issues with Teva products.  You are absolutely correct in your frustration, we definitely owe you a huge apology and a new pair of shoes.  I hope you will accept both from me and know that I will help in finding a resolution.  Teva prides itself on high performance, quality and, as a sign of our camaraderie, our customer service.  I’m sorry to hear we fell short in these department for you.

As you may know, the Aravalli is no longer available in our current line.  However, I would be happy to replace your shoes with a pair from our current selection.  I would like to offer something like the Riva Leather eVent or the Riva eVent.  You can check both out here.  If these aren’t exactly what you’re looking for, just let me know if something else stands out.

Once you choose a style, please let me know your size and address for shipping.  I’ll go ahead and get these out as soon as possible.  Also, for all of your troubles, I would like to also extend an offer for a pair of our Mush flips.  I know it’s starting to change seasons but year-around these are a definitely a treat for your feet.

Thanks again Mike for reaching out.  We’re glad to hear from you and I apologize again, on behalf of Teva, for your troubles.

Looking forward to hearing from you,

jaime

Jaime Eschette

Teva Public Relations

Goleta, CA

(###) ###-### x1178

 please consider the environment before printing this e-mail

After a few email exchanges Teva sent me a pair of Teva Riva Event shoes, These shoes are amazingly comfortable, A little tight at first but after you break in the shoes. they are very light, durable, and weatherproof. I really have to hand it to Teva/Deckers shoes for helping me out and fixing this problem with my shoes.  Really as far as shoes go I never thought of Teva for shoes, I used to use Timberlands for shoes but, as there quality went downhill I was happy to find this brand.